As the glycosylation of DBP isoforms affects the binding affinity for vitamin D metabolites and consequently their circulating levels [39, 40, 41], we can speculate that the degree of DBP glycosylation or the activity of glycosylating/deglycosylating enzymes may have a prognostic and diagnostic value in MS. Here, DBP is linked to myeloid sarcoma.